with Claire Kamaliddin, PhD

9:40 am - 10:10 am in person in ECHA 4-036

Malaria affected 282 million people globally in 2024, and despite the availability of point-of-care methods, malaria diagnostics and infection resolution assessment remain challenged by the parasite's evolution. In this presentation, we will review methods for malaria diagnostics and the implications of host-pathogen dynamics in specific populations and for therapeutic efficacy assessment.

Dr. Claire Kamaliddin is a Pharmacist-Scientist from France. She graduated from her PharmD program at the Faculty of Pharmacy, Paris Descartes University, and holds a Master's in Parasitology and Mycology from the University Pierre and Marie Curie, followed by a PhD in Parasitology at the  Paris Descartes University. Dr. Kamaliddin moved to Canada for her postdoctoral work and recently started an appointment as an Assistant Professor at the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta. Her team, P.O.IN.T (Pathogens Omics INteraction Team) uses multi omics methods to explore host pathogen dynamics, infection clearance, and antimicrobial resistance.